PortfoliosLab logo
AKLI vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AKLI and LLY is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

AKLI vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Akili Inc (AKLI) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%December2025FebruaryMarchAprilMay
-96.93%
137.68%
AKLI
LLY

Key characteristics

Fundamentals

Market Cap

AKLI:

$34.10M

LLY:

$737.66B

EPS

AKLI:

-$0.61

LLY:

$12.27

PS Ratio

AKLI:

12.31

LLY:

15.05

PB Ratio

AKLI:

0.35

LLY:

46.91

Returns By Period


AKLI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

LLY

YTD

-2.49%

1M

3.47%

6M

-5.45%

1Y

-2.41%

5Y*

39.23%

10Y*

28.61%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AKLI vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AKLI
The Risk-Adjusted Performance Rank of AKLI is 2727
Overall Rank
The Sharpe Ratio Rank of AKLI is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of AKLI is 3232
Sortino Ratio Rank
The Omega Ratio Rank of AKLI is 3333
Omega Ratio Rank
The Calmar Ratio Rank of AKLI is 1313
Calmar Ratio Rank
The Martin Ratio Rank of AKLI is 2727
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 4747
Overall Rank
The Sharpe Ratio Rank of LLY is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 4444
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 4343
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 4848
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 4949
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AKLI vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Akili Inc (AKLI) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Rolling 12-month Sharpe Ratio0.000.501.001.50December2025FebruaryMarchAprilMay
0.51
-0.06
AKLI
LLY

Dividends

AKLI vs. LLY - Dividend Comparison

AKLI has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.72%.


TTM20242023202220212020201920182017201620152014
AKLI
Akili Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.72%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%2.84%

Drawdowns

AKLI vs. LLY - Drawdown Comparison


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-96.93%
-21.46%
AKLI
LLY

Volatility

AKLI vs. LLY - Volatility Comparison

The current volatility for Akili Inc (AKLI) is 0.00%, while Eli Lilly and Company (LLY) has a volatility of 22.38%. This indicates that AKLI experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%December2025FebruaryMarchAprilMay0
22.38%
AKLI
LLY

Financials

AKLI vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Akili Inc and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00BJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
383.00K
12.73B
(AKLI) Total Revenue
(LLY) Total Revenue
Values in USD except per share items